Synthesis and biological evaluation of Tc-99m- cyclopentadienyltricarbonyltechnetium-labeled octreotide

Nuclear Medicine and Biology

Volumn 26, Issue 1, 1999, Pages 1-7

  Spradau, Todd W ^a   Edwards, W Barry ^a   Anderson, Carolyn J ^a   Welch, Michael J ^a   Katzenellenbogen, John A ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Cyclopentadienyltricarbonyltechnetium; Double ligand transfer; Octreotide; Somatostatin; Technetium 99m

Indexed keywords

CYCLOPENTADIENE DERIVATIVE; CYCLOPENTADIENYLTRICARBONYLTECHNETIUM TC 99M; OCTREOTIDE; PERTECHNETIC ACID TC 99M; UNCLASSIFIED DRUG;

ADRENAL GLAND; ANIMAL EXPERIMENT; ARTICLE; DRUG SYNTHESIS; DRUG UPTAKE; FEMALE; ISOTOPE LABELING; MOLECULAR WEIGHT; NONHUMAN; PANCREAS; RAT; TISSUE DISTRIBUTION;

ADRENAL GLANDS; ANIMALS; FEMALE; HUMANS; INTESTINES; ISOTOPE LABELING; LIGANDS; LIVER; OCTREOTIDE; ORGAN SPECIFICITY; ORGANOTECHNETIUM COMPOUNDS; PANCREAS; RADIOPHARMACEUTICALS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SOMATOSTATIN; TISSUE DISTRIBUTION;

EID: 0032939815     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(98)00060-2     Document Type: Article

References (18)

1. Amartey J.K. Technetium-99m labeled somatostatin and analogs Synthesis, characterization and in vivo evaluation . Nucl. Med. Biol. 20:1993;539-543.
2. Anderson C.J., Pajeau T.S., Edwards W.B., Sherman E.S.C., Rogers B.E., Welch M.J. In vitro and in vivo evaluation of copper-64-octreotide conjugates. J. Nucl. Med. 36:1995;2315-2325.
3. Bakker W.H., Albert R., Bruns C., Breeman W.A.P., Hofland L.J., Marbach P., Pless J., Pralet D., Stolz B., Koper J.W., Lamberts S.W.J., Visser T.J., Kenning E.P. (111-In-DTPA-D-Phe1)-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors Synthesis, radiolabeling and in vitro validation . Life Sci. 49:1991;1583-1591.
4. Breeman W.A.P., Kwekkeboom D.J., Kooij P.P.M., Bakker W.H., Hofland L.J., Visser T.J., Ensing G.J., Lamberts S.W.J., Krenning E.P. Effect of dose and specific activity on tissue distribution of indium-111-pentetreotide in rats. J. Nucl. Med. 36:1995;623-627.
5. Dörr U., Räth U., Sautter-Bihl M., Guzman G., Bach D., Adrian H., Bihl H. Improved visualization of carcinoid liver metastases by indium-111-pentetreotide scintigraphy following treatment with cold somatostatin analogue. Eur. J. Nucl. Med. 20:1993;431-433.
6. Kolan H., Li J., Thakur M.L. Sandostatin® labeled with 99m-Tc In vitro stability, in vivo validity and comparison with 111-In-DTPA-octreotide . Pept. Res. 9:1996;144-150.
7. Krenning E.P., Kwekkeboom D.J., Bakker W.H., Breeman W.A., Kooij P.P., Oei H.Y., van Hagen M., Postema P.T., de Jong M., Reubi J.C. Somatostatin receptor scintigraphy with [In-111-DTPA-D-Phe] and [I-123-Tyr-3] octreotide; the Rotterdam experience with more than 1000 patients. Eur. J. Nucl. Med. 20:1993;716-731.
8. Kuntschke D. (1994) Tc-99m-Cytectrene-Darstellung, Biochemische Untersuchungen und Beitrage zur Aufklarung des Reaktionsmechanismus. Ph.D. Thesis, Freien Universitat Berlin, Berlin, Germany, 131 pp.
9. Kvols L.K. Somatostatin-receptor imaging of human malignancies A new era in the localization, staging, and treatment of tumors . Gastroenterology. 105:1993;1909-1914.
10. Maina T., Stolz B., Albert R., Bruns C., Koch P., Mäcke H. Synthesis, radiochemistry and biological evaluation of a new somatostatin analogue (SDZ 219-387) labelled with technetium-99m. Eur. J. Nucl. Med. 21:1994;437-444.
11. Paik C.H., Phan L.N.B., Hong J.J. The labeling of high affinity sites of antibodies with 99m-Tc. Int. J. Nucl. Med. Biol. 12:1985;3-8.
12. Pearson D.A., Lister-James J., McBride W.J., Wilson D.M., Martel L.J., Civitello E.R., Taylor J.E., Moyer B.R., Dean R.T. Somatostatin receptor-binding peptides labeled with technetium-99m Chemistry and initial biological studies . J. Med. Chem. 39:1996;1361-1371.
13. Reubi J.C., Lamberts S.J.W., Krenning E.P. Receptor imaging of human diseases using radiolabeled peptides. J. Receptor Signal Transduction Res. 15:1995;379-392.
14. Spradau T. W. and Katzenellenbogen J. A. (in press) Protein and peptide labeling with cyclopentadienyltricarbonylrhenium and technetium. Bioconjugate Chem.
15. Spradau T.W., Katzenellenbogen J.A. Preparation of cyclopentadienyltricarbonylrhenium complexes using a double ligand transfer reaction. Organometallics. 17:1998;2009-2017.
16. Thakur M.L., Kolan H., Li J., Wiaderkiewicz R., Pallela V.R., Duggaraju R., Schally A.V. Radiolabeled somatostatin analogs in prostate cancer. Nucl. Med. Biol. 24:1997;105-113.
17. Vallabhafosula S., Moyer B.R., Lister-James J., McBride B.J., Lipszyc H., Lee H., Bastidas D., Dean R.T. Preclinical evaluation of technetium-99m-labeled somatostatin receptor-binding peptides. J. Nucl. Med. 37:1996;1016-1022.
18. Wenzel M. Tc-99m labelling of Cymantrene-analogues with different substituents. A new approach to Tc-99m radiodiagnostics. J. Labelled Compd. Radiopharm. 31:1992;641-650.